These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37236847)

  • 1. Factors influencing pharmacists' clinical decision making in pharmacy practice.
    Mertens JF; Koster ES; Deneer VHM; Bouvy ML; van Gelder T
    Res Social Adm Pharm; 2023 Sep; 19(9):1267-1277. PubMed ID: 37236847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive processes in pharmacists' clinical decision-making.
    Mertens JF; Kempen TGH; Koster ES; Deneer VHM; Bouvy ML; van Gelder T
    Res Social Adm Pharm; 2024 Feb; 20(2):105-114. PubMed ID: 37945418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital pharmacists' ethical exposure and decision-making.
    So B; Tuche M; King MA; Hope DL; La Caze A; Hattingh HL
    Res Social Adm Pharm; 2021 Feb; 17(2):372-380. PubMed ID: 32284299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial.
    Bertilsson E; Serhal S; Emmerton L; Bosnic-Anticevich S; Krass I; Bereznicki B; Bereznicki L; Armour C; Saini B
    Res Social Adm Pharm; 2021 Mar; 17(3):595-605. PubMed ID: 32448767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring community pharmacists' clinical decision-making using think aloud and protocol analysis.
    Mallinder A; Martini N
    Res Social Adm Pharm; 2022 Apr; 18(4):2606-2614. PubMed ID: 33985891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enablers and challenges to pharmacy practice change in Kuwait hospitals: a qualitative exploration of pharmacists' perceptions.
    Katoue MG
    J Eval Clin Pract; 2021 Apr; 27(2):272-279. PubMed ID: 32929812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Ethical Pharmacy Practice in Jordan.
    Fino LB; Basheti IA; Chaar BB
    Sci Eng Ethics; 2020 Oct; 26(5):2809-2834. PubMed ID: 32533448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful implementation and provision of enhanced and extended pharmacy services.
    Hattingh L; Sim TF; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):464-474. PubMed ID: 31272922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative study on community pharmacists' decision-making process when making a diagnosis.
    Sinopoulou V; Summerfield P; Rutter P
    J Eval Clin Pract; 2017 Dec; 23(6):1482-1488. PubMed ID: 28990319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded practice in rural community pharmacy: a macro-, meso and micro-level perspective.
    Taylor S; Cairns A; Glass B
    Rural Remote Health; 2021 Jul; 21(3):6158. PubMed ID: 34304577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists.
    Czarniak P; Chalmers L; Hughes J; Iacob R; Lee YP; Parsons K; Parsons R; Sunderland B; Sim TF
    Int J Clin Pharm; 2022 Apr; 44(2):466-479. PubMed ID: 35088232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacists' views and experiences of delivering in-pharmacy medication reviews for people living with severe and persistent mental illness: a qualitative study.
    Ng R; El-Den S; Collins JC; McMillan SS; Hu J; Wheeler AJ; O'Reilly CL
    Int J Clin Pharm; 2024 Aug; 46(4):862-871. PubMed ID: 38551748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community Pharmacists' Perspectives of a Decision Aid for Managing Type 2 Diabetes in Ontario.
    Verweel L; Gionfriddo MR; MacCallum L; Dolovich L; Rosenberg-Yunger ZRS
    Can J Diabetes; 2017 Dec; 41(6):587-595. PubMed ID: 29224635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacists' and residents' decision making and unmet information needs when completing comprehensive medication reviews.
    McPherson KL; Adeoye-Olatunde OA; Osborne JM; Doucette WR; Gernant SA; Jaynes H; Phansalkar S; Russ-Jara AL; Snyder ME
    J Am Pharm Assoc (2003); 2020; 60(3S):S41-S50.e2. PubMed ID: 31987810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia.
    Nielsen S; Olsen A
    Int J Drug Policy; 2021 Apr; 90():103061. PubMed ID: 33321285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists' perceptions and delivery of health behaviour change recommendations: Mapping the COM-B model.
    Maxwell-Smith C; Breare H; Dominguez Garcia A; Sim TF; Blackford K; Chih HJ; Jancey J; Mullan BA
    Res Social Adm Pharm; 2024 Feb; 20(2):115-123. PubMed ID: 37926620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on an amended law addressing pharmacists' availability in community pharmacies.
    Qadeer G; Amin MEK
    J Eval Clin Pract; 2021 Feb; 27(1):151-157. PubMed ID: 32319720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.